Vol. 13 (2020): KJM Supplement 2: Frontiers Edition

• Table of Contents

  • PDF

Preface

• Preface Frontiers Edition February 2020

  KJM Editors

  1

  • PDF

Original Research

• A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine

  Dipika Aggarwal, M.D., Andrew J. Heim, CCRP, Brennen Bittel, D.O., Deetra Ford, M.D., Richard Dubinsky, M.D., Gary Gronseth, M.D., Vernita Hairston, M.D., Patrick Landazuri, M.D., Fred Sachen, M.D., Laura Herbelin, CCRP, Richard J. Barohn, M.D.

  2-5

  • PDF

• Development of Silica-Immobilized Vaccines for Improving Thermo-Tolerance and Shelf-Life

  Nicole Montoya, B.S, Ch.E., Kaylee Barr, Brian Kirchhoff, Edward Reyes, Jorge Umana, Kalena Nichol, Eric Hartman, William Picking, Ph.D., Fei Phillip Gao, Ph.D., David R. Corbin, Ph.D., Mark B. Shiflett, Ph.D.

  6-9

  • PDF

• Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial

  Mamatha Pasnoor, M.D., Andrew J. Heim, CCRP, Laura Herbelin, CCRP, Jeffrey Statland, M.D., Mazen M. Dimachkie, M.D., Mara Becker, M.D., Richard J. Barohn, M.D.

  10-13

  • PDF

Commentary

• Development of GCRC and CTSA Programs at the University of Kansas Medical Center A Personal 10-year Perspective

  Richard J. Barohn, M.D.

  14-19

  • PDF

• Navigating the NIH Public Access Policy for Peer-Reviewed Manuscripts Why and How to get a PMCID Number

  Robin Liston, MPH, Richard J. Barohn, M.D.

  20-23

  • PDF

• Step-by-Step Guide for Setting up a Company in Kansas and Missouri

  James W. Mitchell, Ph.D, Steve O’Connor, Ph.D., Maria Meyers, Rajiv Kulkarni, Richard J. Barohn, M.D.

  24-25

  • PDF

• Dedicated to the Pipeline KU Frontiers’ Pursuit of Maintaining and Cultivating the Careers of Current and Future Physician- Scientists

  Amy M. Smith, M.S., MBA, Won S. Choi, Ph.D.

  26-28

  • PDF

Letters to the Editor

• Letter to the Editor: A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine

  John C. Hagan III, M.D., FACS, FAAO

  29-30

  • PDF

Meeting Abstracts

• Abstracts from Frontiers Research Day University of Kansas Medical Center, Kansas City, KS March 4, 2020

  KJM Editors

  31-62

  • PDF